Northrop Grumman Down Nearly 6%, on Pace for Largest Percent Decrease Since November 2022 — Data Talk
Northrop Grumman Corp. (NOC) is currently at $436.52, down $27.40 or 5.91%
--Would be lowest close since Oct. 6, 2023, when it closed at $423.24
--On pace for largest percent decrease since Nov. 11, 2022, when it fell 7.32%
--Currently down four of the past five days
--Currently down two consecutive days; down 6.71% over this period
--Worst two day stretch since the two days ending Nov. 14, 2022, when it fell 9.38%
--Down 6.75% month-to-date
--Down 6.75% year-to-date
--Down 20.49% from its all-time closing high of $549.01 on Oct. 31, 2022
--Down 1.57% from 52 weeks ago (Jan. 26, 2023), when it closed at $443.47
--Down 11.05% from its 52-week closing high of $490.76 on Oct. 18, 2023
--Up 3.92% from its 52-week closing low of $420.07 on Oct. 5, 2023
--Traded as low as $435.00; lowest intraday level since Oct. 6, 2023, when it hit $414.56
--Down 6.23% at today's intraday low; largest intraday percent decrease since Jan. 13, 2023, when it fell as much as 6.8%
--Third worst performer in the S&P 500 today
All data as of 10:02:56 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 25, 2024 10:20 ET (15:20 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?